Multimodality Therapy for Stage IIIA (N2) Lung Cancer: An Overview
作者： Robert J. Ginsberg
DOI: 10.1378/CHEST.103.4_SUPPLEMENT.356S
关键词:
摘要: Determination of the eventual role aggressive, multimodality therapy in treatment locally advanced lung cancer awaits results these and other trials. Ultimately, however, it is hoped that studies will lead to improved prospects for many patients who present with was previously considered inoperable.
sci-hub.se 参考文章(14)
F.G. Pearson, N.C. DeLarue, R. lives, T.R.J. Todd, J.D. Cooper, Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 83, pp. 1- 11 ,(1982) , 10.1016/S0022-5223(19)37318-0
Tsuguo Naruke, Tomoyuki Goya, Ryosuke Tsuchiya, Keiichi Suemasu, Prognosis and survival in resected lung carcinoma based on the new international staging system. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 96, pp. 440- 447 ,(1988) , 10.1016/S0022-5223(19)35243-2
E. CARMACK HOLMES, LUCIUS D. HILL, MITCHELL GAIL, A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group. Annals of Surgery. ,vol. 202, pp. 335- 341 ,(1985) , 10.1097/00000658-198509000-00010
R L Burkes, R J Ginsberg, F A Shepherd, M E Blackstein, M E Goldberg, P F Waters, G A Patterson, T Todd, F G Pearson, J D Cooper, Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial. Journal of Clinical Oncology. ,vol. 10, pp. 580- 586 ,(1992) , 10.1200/JCO.1992.10.4.580
L.Penfield Faber, C.Frederick Kittle, William H. Warren, Philip D. Bonomi, Samuel G. Taylor, Salitha Reddy, Myung-Sook Lee, Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer The Annals of Thoracic Surgery. ,vol. 47, pp. 669- 677 ,(1989) , 10.1016/0003-4975(89)90115-X
Arthur Skarin, Maxine Jochelson, Thomas Sheldon, Arnold Malcolm, Peter Oliynyk, Richard Overholt, Myla Hunt, Emil Frei, Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: Long-term follow-up in 41 patients Journal of Surgical Oncology. ,vol. 40, pp. 266- 274 ,(1989) , 10.1002/JSO.2930400413
Harvey I. Pass, Helen W. Pogrebniak, Seth M. Steinberg, James Mulshine, John Minna, Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis The Annals of Thoracic Surgery. ,vol. 53, pp. 992- 998 ,(1992) , 10.1016/0003-4975(92)90373-C
Yoh Watanabe, Yoshinobu Hayashi, Junzo Shimizu, Makoto Oda, Takashi Iwa, Mediastinal nodal involvement and the prognosis of non-small cell lung cancer. Chest. ,vol. 100, pp. 422- 428 ,(1991) , 10.1378/CHEST.100.2.422
J D Cox, N Azarnia, R W Byhardt, K H Shin, B Emami, T F Pajak, A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. Journal of Clinical Oncology. ,vol. 8, pp. 1543- 1555 ,(1990) , 10.1200/JCO.1990.8.9.1543
Caro Schaake-Koning, Walter van den Bogaert, Otilia Dalesio, Jan Festen, Jaap Hoogenhout, Paul van Houtte, Anne Kirkpatrick, Mia Koolen, Ben Maat, Arie Nijs, Alain Renaud, Patrick Rodrigus, Lon Schuster-Uitterhoeve, Jean-Paul Sculier, Nico van Zandwijk, Harry Bartelink, Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 326, pp. 524- 530 ,(1992) , 10.1056/NEJM199202203260805